Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors ; day:30 ; month:03 ; year:2021 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; (30.03.2021) (gesamt 3)
- Urheber
-
Angers, Stephane
- DOI
-
10.15252/emmm.202114002
- URN
-
urn:nbn:de:101:1-2021033115144148480695
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Angers, Stephane
Ähnliche Objekte (12)
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Modeling synthetic lethality
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Modeling synthetic lethality
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Modeling synthetic lethality
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells